Q96NA2 (RILP_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 16, 2012.
Version 88.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Rab-interacting lysosomal protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 401 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Rab effector playing a role in late endocytic transport to degradative compartments. Involved in the regulation of lysosomal morphology and distribution. Induces recruitment of dynein-dynactin motor complexes to Rab7A-containing late endosome and lysosome compartments. Promotes centripetal migration of phagosomes and the fusion of phagosomes with the late endosomes and lysosomes. Ref.1 Ref.7 Ref.9 Ref.10 |
| Subunit structure | Homodimer. Each subunit can interact with either RAB7A or RAB34. Ref.11 Ref.13 |
| Subcellular location | Endomembrane system. Late endosome membrane. Lysosome membrane. Cytoplasmic vesicle › phagosome membrane. Note: Associated with late endosomal, lysosomal and phagosomal membranes. The interaction with RAB7A is necessary for its recruitment to phagosomes. Ref.1 Ref.9 Ref.10 |
| Tissue specificity | Ubiquitous. Strongly expressed in fetal heart, heart, stomach, spleen, adrenal gland, thyroid gland, salivary gland, fetal liver, liver and lung. Poorly expressed in brain. Ref.1 Ref.6 Ref.10 |
| Sequence similarities | Contains 1 RILP-like domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Protein transport Transport |
| Cellular component | Cytoplasmic vesicle Endosome Lysosome Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Coiled coil |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | endosome to lysosome transport Inferred from mutant phenotype PubMed 18272684. Source: BHF-UCL protein transportNon-traceable author statement Ref.1. Source: UniProtKB |
| Cellular component | late endosome membrane Inferred from electronic annotation. Source: UniProtKB-SubCell lysosomal membraneNon-traceable author statement Ref.1. Source: UniProtKB phagocytic vesicle membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | Rab GTPase binding Traceable author statement Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96NA2-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96NA2-2) The sequence of this isoform differs from the canonical sequence as follows: 1-210: Missing. 211-213: WAT → MGA |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 401 | 401 | Rab-interacting lysosomal protein | PRO_0000097339 | |||||||||
Regions | |||||||||||||
| Domain | 236 – 270 | 35 | RILP-like | ||||||||||
| Region | 272 – 333 | 62 | Necessary for the interaction with RAB7A and RAB34, lysosomal distribution and morphology | ||||||||||
| Coiled coil | 75 – 181 | 107 | Potential | ||||||||||
Amino acid modifications | |||||||||||||
| Modified residue | 314 | 1 | Phosphoserine Ref.12 | ||||||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.12 | ||||||||||
Natural variations | |||||||||||||
| Alternative sequence | 1 – 210 | 210 | Missing in isoform 2. | VSP_016043 | |||||||||
| Alternative sequence | 211 – 213 | 3 | WAT → MGA in isoform 2. | VSP_016044 | |||||||||
| Natural variant | 81 | 1 | A → T. Ref.2 Corresponds to variant rs9909321 [ dbSNP | Ensembl ]. | VAR_051321 | |||||||||
| Natural variant | 281 | 1 | R → Q. Corresponds to variant rs34982553 [ dbSNP | Ensembl ]. | VAR_034417 | |||||||||
Experimental info | |||||||||||||
| Mutagenesis | 248 | 1 | F → A: Strongly reduces dimerization and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 251 | 1 | I → A: Abolishes dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 252 | 1 | L → A: Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 255 | 1 | R → A: Abolishes dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 258 | 1 | L → A: Reduces dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 304 | 1 | K → A: Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 305 | 1 | M → A: Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Mutagenesis | 306 | 1 | L → A: Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments. Ref.13 | ||||||||||
| Sequence conflict | 284 | 1 | G → S in CAC33443. Ref.1 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Helix | 248 – 276 | 29 | |||||||||||
| Helix | 284 – 306 | 23 | |||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes." Cantalupo G., Alifano P., Roberti V., Bruni C.B., Bucci C. EMBO J. 20:683-693(2001) [PubMed: 11179213] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN LATE ENDOCYTOSIS, INTERACTION WITH RAB7A, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Cervix carcinoma. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT THR-81. Tissue: Kidney and Thalamus. |
| [3] | "Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. Gu J.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed: 15498874] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "Study of 100 skeletal muscle full length mRNA (Telethon project B41)." Frigimelica E., Lanfranchi G. Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Skeletal muscle. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain, Lung, Testis and Uterus. |
| [6] | "Expression analysis and chromosomal assignment of PRA1 and RILP genes." Bucci C., De Gregorio L., Bruni C.B. Biochem. Biophys. Res. Commun. 286:815-819(2001) [PubMed: 11520070] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [7] | "The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors." Jordens I., Fernandez-Borja M., Marsman M., Dusseljee S., Janssen L., Calafat J., Janssen H., Wubbolts R., Neefjes J. Curr. Biol. 11:1680-1685(2001) [PubMed: 11696325] [Abstract] Cited for: FUNCTION IN DYNEIN-DYNACTIN COMPLEX RECRUITMENT. |
| [8] | "Interorganellar regulation of lysosome positioning by the Golgi apparatus through Rab34 interaction with Rab-interacting lysosomal protein." Wang T., Hong W. Mol. Biol. Cell 13:4317-4332(2002) [PubMed: 12475955] [Abstract] Cited for: INTERACTION WITH RAB34. |
| [9] | "Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP." Harrison R.E., Bucci C., Vieira O.V., Schroer T.A., Grinstein S. Mol. Cell. Biol. 23:6494-6506(2003) [PubMed: 12944476] [Abstract] Cited for: FUNCTION IN PHAGOSOME MIGRATION AND PHAGOLYSOSOMAL FUSION, SUBCELLULAR LOCATION. |
| [10] | "A unique region of RILP distinguishes it from its related proteins in its regulation of lysosomal morphology and interaction with Rab7 and Rab34." Wang T., Wong K.K., Hong W. Mol. Biol. Cell 15:815-826(2004) [PubMed: 14668488] [Abstract] Cited for: FUNCTION IN LYSOSOMAL MORPHOLOGY AND DISTRIBUTION, INTERACTION WITH RAB7A AND RAB34, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [11] | "The Rab-interacting lysosomal protein, a Rab7 and Rab34 effector, is capable of self-interaction." Colucci A.M.R., Campana M.C., Bellopede M., Bucci C. Biochem. Biophys. Res. Commun. 334:128-133(2005) [PubMed: 15996637] [Abstract] Cited for: SUBUNIT. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-314 AND SER-315, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Structural basis for recruitment of RILP by small GTPase Rab7." Wu M., Wang T., Loh E., Hong W., Song H. EMBO J. 24:1491-1501(2005) [PubMed: 15933719] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 244-308 IN COMPLEX WITH RAB7A, SUBUNIT, MUTAGENESIS OF PHE-248; ILE-251; LEU-252; ARG-255; LEU-258; LYS-304; MET-305 AND LEU-306. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AJ404317 mRNA. Translation: CAC33443.1. AK055755 mRNA. Translation: BAB71003.1. AK314767 mRNA. Translation: BAG37305.1. AF370391 mRNA. Translation: AAQ15227.1. AJ278711 mRNA. Translation: CAC82174.1. BC004961 mRNA. Translation: AAH04961.1. BC031621 mRNA. Translation: AAH31621.1. | ||||||||||||
| IPI | IPI00289188. IPI00654568. | ||||||||||||
| RefSeq | NP_113618.2. NM_031430.2. | ||||||||||||
| UniGene | Hs.534497. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96NA2. | ||||||||||||
| SMR | Q96NA2. Positions 244-308. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q96NA2. 3 interactions. | ||||||||||||
| STRING | Q96NA2. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96NA2. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 74732524. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q96NA2. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 83547. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000301336; ENSP00000301336; ENSG00000167705. | ||||||||||||
| GeneID | 83547. | ||||||||||||
| KEGG | hsa:83547. | ||||||||||||
| UCSC | uc002ftd.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 83547. | ||||||||||||
| GeneCards | GC17M001549. | ||||||||||||
| H-InvDB | HIX0202439. | ||||||||||||
| HGNC | HGNC:30266. RILP. | ||||||||||||
| MIM | 607848. gene. | ||||||||||||
| neXtProt | NX_Q96NA2. | ||||||||||||
| PharmGKB | PA134915969. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG28812. | ||||||||||||
| GeneTree | ENSGT00530000063269. | ||||||||||||
| HOGENOM | HOG000007529. | ||||||||||||
| HOVERGEN | HBG082629. | ||||||||||||
| InParanoid | Q96NA2. | ||||||||||||
| KO | K13883. | ||||||||||||
| OMA | KVAVKKQ. | ||||||||||||
| OrthoDB | EOG415GDV. | ||||||||||||
| PhylomeDB | Q96NA2. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96NA2. | ||||||||||||
| Bgee | Q96NA2. | ||||||||||||
| CleanEx | HS_RILP. | ||||||||||||
| Genevestigator | Q96NA2. | ||||||||||||
| GermOnline | ENSG00000167705. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR019143. JNK/Rab-associated_protein-1_N. IPR021563. RILP. [Graphical view] | ||||||||||||
| Pfam | PF09744. Jnk-SapK_ap_N. 1 hit. PF11461. RILP. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q96NA2. | ||||||||||||
| NextBio | 72481. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | RILP_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96NA2 Secondary accession number(s): B2RBQ8 Q9BYS3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with